List of Excipients in API loperamide hydrochloride and simethicone
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing loperamide hydrochloride and simethicone
Detailed excipient profiles for loperamide hydrochloride and simethicone
Excipient focus: ACESULFAME POTASSIUM
loperamide hydrochloride and simethicone drug variants containing ACESULFAME POTASSIUM
loperamide hydrochloride and simethicone drug variants not containing ACESULFAME POTASSIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: ANHYDROUS DIBASIC CALCIUM PHOSPHATE
loperamide hydrochloride and simethicone drug variants containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
loperamide hydrochloride and simethicone drug variants not containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
| Company | Ingredient | NDC |
|---|---|---|
| Camber Consumer Care Inc | loperamide hydrochloride and simethicone | 69230-325 |
| Bionpharma Inc | loperamide hydrochloride and simethicone | 69452-210 |
| >Company | >Ingredient | >NDC |
Excipient focus: CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS
loperamide hydrochloride and simethicone drug variants containing CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS
| Company | Ingredient | NDC |
|---|---|---|
| Camber Consumer Care Inc | loperamide hydrochloride and simethicone | 69230-325 |
| Bionpharma Inc | loperamide hydrochloride and simethicone | 69452-210 |
| >Company | >Ingredient | >NDC |
loperamide hydrochloride and simethicone drug variants not containing CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS
Excipient focus: CELLULOSE, MICROCRYSTALLINE
loperamide hydrochloride and simethicone drug variants containing CELLULOSE, MICROCRYSTALLINE
loperamide hydrochloride and simethicone drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: CROSCARMELLOSE SODIUM
loperamide hydrochloride and simethicone drug variants containing CROSCARMELLOSE SODIUM
loperamide hydrochloride and simethicone drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MICROCRYSTALLINE CELLULOSE 101
loperamide hydrochloride and simethicone drug variants containing MICROCRYSTALLINE CELLULOSE 101
loperamide hydrochloride and simethicone drug variants not containing MICROCRYSTALLINE CELLULOSE 101
Excipient focus: MICROCRYSTALLINE CELLULOSE 102
loperamide hydrochloride and simethicone drug variants containing MICROCRYSTALLINE CELLULOSE 102
loperamide hydrochloride and simethicone drug variants not containing MICROCRYSTALLINE CELLULOSE 102
Excipient focus: SILICON DIOXIDE
loperamide hydrochloride and simethicone drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Granules India Ltd | loperamide hydrochloride and simethicone | 62207-739 |
| Bionpharma Inc | loperamide hydrochloride and simethicone | 69452-210 |
| >Company | >Ingredient | >NDC |
loperamide hydrochloride and simethicone drug variants not containing SILICON DIOXIDE
Excipient focus: STEARIC ACID
loperamide hydrochloride and simethicone drug variants containing STEARIC ACID
loperamide hydrochloride and simethicone drug variants not containing STEARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: VANILLA
loperamide hydrochloride and simethicone drug variants containing VANILLA
| Company | Ingredient | NDC |
|---|---|---|
| Bionpharma Inc | loperamide hydrochloride and simethicone | 69452-210 |
| >Company | >Ingredient | >NDC |
loperamide hydrochloride and simethicone drug variants not containing VANILLA
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch